Table 1 (abstract 175). Demographical data and evolution of different disease groups

Number of patients (families)

21

(19)

5

(5)

16

(15)

38

(34)

20

(20)

61

(61)

5

(5)

166

(159)

Gender (M;F)

8;13

1;4

5;11

16;22

12;8

18;43

2;3

62;104

Age at disease onset* (years)

0†

(0†-11)

5,5

(0-11)

1

(0†-11)

3

(0-9)

6

(0-12)

9.5

(3-14)

8

(4-15)

8

(0-15)

Duration of follow-up* (years)

7

(0,5-26)

3,75

(0-9)

4,25

(0-18)

3,5

(1-18)

2,75

(0-16)

12.5

(0-17)

2

(0-2,5)

8

(0-26)

Complications or side effects (%)

15

(71)

3

(60)

9

(56)

9

(23)

15

(75)

15

(24)

1

(20)

67

(40)

Number of biologic DMRADs*

2

(1-3)

1

(1-1)

2

(0-4)

0

(0-2)

0

(0-2)

0

(0-1)

0

(0-0)

0

(0-4)

Clinical remission on treatment (%)

18

(85)

0

(0)

9

(56)

24

(63)

7

(35)

15

(24)

0

(0)

73

(44)

Clinical remission off treatment (%)

0

(0)

1

(20)

0

(0)

2

(5)

0

(0)

13

(21)

3

(60)

19

(11.5)

Relapse after remissions (%)

2

(9)

1

(20)

3

(18)

1

(2)

0

(0)

7

(11)

0

(0)

14

(8)